Acute Beta-Blockade Reduces the Extent and Severity of Myocardial Perfusion Defects with Dipyridamole Tc-99m Sestamibi SPECT Imaging

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1475-1483

  Taillefer, Raymond ^a   Ahlberg, Alan W ^b   Masood, Yasmin ^b   White, C Michael ^c   Lamargese, Isabella ^a   Mather, Jeffrey F ^c   McGill, Carol C ^b   Heller, Gary V ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOPROLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HEART MUSCLE PERFUSION; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

EID: 0142107354     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01046-5     Document Type: Article

References (37)

1. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14: 1477-86.
2. Heller GV, Ahmed I, Tilkemeier PL, Barbour MM, Garber CE. Influence of exercise intensity on the presence, distribution, and size of thallium-201 defects. Am Heart J 1992;123:909-16.
3. Heller GV, Ahmed I, Tilkemeier PL, Barbour MM, Garber CE. Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris. Am J Cardiol 1991;68:569-74.
4. Frisch C, DeSanctis R, Doge H, Reeves T, Weinberg S. Guidelines for exercise testing: a report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). J Am Coll Cardiol 1986;8:725-38.
5. Hockings B, Saltissi S, Croft DN, Webb-Peploe MM. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging. Br Heart J 1983;49:83-9.
6. Martin GJ, Henkin RE, Scanlon PJ. Beta blockers and the sensitivity of the thallium treadmill test. Chest 1987;92:486-7.
7. Burns RJ, Kruzyk GC, Armitage DL, Druck MN. Effect of anti-anginal medications on the prognostic value of exercise thallium scintigraphy. Can J Cardiol 1989;5:29-32.
8. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994;24: 25-32.
9. Shehata AR, Gillam L, Mascitelli V, et al. Impact of acute propranalol administration on dobutamine induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997;80:268-72.
10. Smits P, Corstens FHM, Aengevaeren WRM, Wackers FJT, Thien T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med 1991;32:1538-41.
11. Heller GV, Dweik RB, Barbour MM, et al. Pretreatment with theophylline does not affect adenosine-induced thallium-201 myocardial imaging. Am Heart J 1993;126:1077-83.
12. Beller GA. Dipyridamole thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy. J Am Coll Cardiol 1989;14: 1642-4.
13. Bonaduce D, Muto P, Morgano G, et al. Effect of beta blockade on thallium-201 dipyridamole myocardial scintigraphy. Acta Cardiol 1984;39:399-408.
14. Picano E. Dipyridamole echocardiography test/historical background and physiologic basis. Eur Heart J 1989;10:365-76.
15. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-6.
16. Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross J. Effects of β-blockade on regional myocardial flow and function during exercise. Am J Physiol 1984;247:H52-60.
17. Narahar K, Thompson C, Hazen J, Brizendine M, Mena I. The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease. Am Heart J 1989;117:1030-5.
18. Hockings B, Saltissi S. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging. Br Heart J 1983;49:83-9.
19. Muller-Suur R, Eiksson S, Strandber L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. Cardiology 2001;95:112-8.
20. Lattanzi F, Picano E. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Circulation 1991;83:1256-62.
21. Kubota I, Ikeda K, Igarashi H. Inhibition of dipyridamole-induced myocardial ischemia by diltiazem in patients with coronary artery disease. J Cardiovasc Pharmacol 1987;9:363-7.
22. Santoro G, Sciagra R, Buonamici P, Consoli N, Mazzoni V. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998;1:19-27.
23. Bridges A, Kennedy N, McNeill G. The effect of atenolol on dipyridamole 201Tl myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun 1992;13:41-6.
24. Picano E. Dipyridamole echocardiography test: historical background and physiologic basis. Eur Heart J 1989;10:365-72.
25. United States Pharmacopeial Convention. USPDI-Volume I, Drug Information for the Health Professional. Englewood, CO: Micromedex, Inc., 2000.
26. Second messenger systems. In: Clark WG, Brater DC, Johnson AR, editors. Goth's Medical Pharmacology. St Louis, MO: Mosby Year Book, 1992:13-7.
27. Katzung BG, Chatterjee K. Vasodilators and the treatment of angina pectoris. In: Katzung BG, editor. Basic & Clinical Pharmacology. New York, NY: McGraw-Hill, 2001:181-99.
28. Young DF, Tsai FY. Flow characteristics in models of arterial stenosis. I. Steady flow. J Biomech 1973;6:395-410.
29. Young DF, Tsai FY. Flow characteristics in models of arterial stenosis: II. Unsteady flow. J Biomech 1973;6:547-59.
30. Gould KL, Lipscomb K, Calvert C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 1975;51:1085-94.
31. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
32. Flameng W, Wusten B, Schaper W. On the distribution of myocardial flow. II. Effects of arterial stenosis and vasodilation. Basic Res Cardiol 1974;69:435-46.
33. Becker LC. Conditions of vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57:1103-10.
34. Becker LC. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion. J Clin Invest 1976;58:1287-96.
35. Nakamura M, Nakayaki O, Nose Y, Fukuyama T, Kikuchi Y. Effects of nitroglycerin and dipyridamole on regional myocardial blood flow. Basic Res Cardiol 1978;73:482-96.
36. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
37. Sundereswaran L, He ZX, Verani MS, Mahmarian JJ. Influence of anti-anginal medications on the detection of coronary artery disease as assessed by single photon emission computed tomography combined with adenosine stress (abstr). Circulation 1996;94 Suppl I:I303.